A narrative review examined Enhanced Recovery After Surgery (ERAS) protocols for patients undergoing orthognathic surgery. These protocols include multimodal pain management, hemorrhage control, nausea prevention, airway care, steroid use, and fluid management. The review looked at outcomes like opioid use, hospital stay length, and overall recovery. Results suggest ERAS can reduce opioid consumption, shorten hospital stays, and improve recovery. No safety concerns or adverse events were reported in this review. However, the study has important limitations. There is no single standardized ERAS protocol universally adopted for this surgery yet. The authors note that further research and a unified protocol with specific anesthesia guidelines are needed. This review provides insights into applying ERAS in orthognathic surgery and offers guidance for clinical practice. Readers should understand that while these protocols show promise, more work is required to standardize their use. This information helps clinicians consider options for improving patient outcomes in this specific surgical area.
ERAS protocols show promise for orthognathic surgery recovery
Photo by Oscar Ochoa / Unsplash
What this means for you:
ERAS protocols may help reduce opioid use and shorten stays for jaw surgery patients, but standardized guidelines are still needed. More on opioids
Meta-analysis shows VR reduces pain in adult ICU patients receiving conventional care Virtual reality headsets lower pain scores for adults in the ICU
Frontiers · May 19, 2026
Brepocitinib 30 mg improved Total Improvement Score versus placebo in dermatomyositis patients over 52 weeks New Pill Eases Stubborn Muscle and Skin Disease Symptoms
· May 14, 2026
Hybrid NLP and LLM system extracts deprescribing recommendations from electronic health records for older hospitalized patients New tool helps doctors stop unnecessary drugs for older hospital patients
medRxiv · May 1, 2026
Stapokibart plus glucocorticoids achieves disease control in elderly bullous pemphigoid patients Trial shows stapokibart helps elderly bullous pemphigoid patients
Frontiers · Apr 24, 2026